105 related articles for article (PubMed ID: 24094914)
1. Discussion.
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):516. PubMed ID: 24094914
[No Abstract] [Full Text] [Related]
2. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
[TBL] [Abstract][Full Text] [Related]
3. Role of hedgehog signaling in malignant pleural mesothelioma.
Shi Y; Moura U; Opitz I; Soltermann A; Rehrauer H; Thies S; Weder W; Stahel RA; Felley-Bosco E
Clin Cancer Res; 2012 Sep; 18(17):4646-56. PubMed ID: 22733539
[TBL] [Abstract][Full Text] [Related]
4. Hedgehog pathway inhibition and the race against tumor evolution.
Atwood SX; Chang AL; Oro AE
J Cell Biol; 2012 Oct; 199(2):193-7. PubMed ID: 23071148
[TBL] [Abstract][Full Text] [Related]
5. Arsenic: a potentially useful poison for Hedgehog-driven cancers.
Raju GP
J Clin Invest; 2011 Jan; 121(1):14-6. PubMed ID: 21183780
[TBL] [Abstract][Full Text] [Related]
6. Targeting GLI factors to inhibit the Hedgehog pathway.
Infante P; Alfonsi R; Botta B; Mori M; Di Marcotullio L
Trends Pharmacol Sci; 2015 Aug; 36(8):547-58. PubMed ID: 26072120
[TBL] [Abstract][Full Text] [Related]
7. Cul4A overexpression associated with Gli1 expression in malignant pleural mesothelioma.
Yang YL; Ni J; Hsu PC; Mao JH; Hsieh D; Xu A; Chan G; Au A; Xu Z; Jablons DM; You L
J Cell Mol Med; 2015 Oct; 19(10):2385-96. PubMed ID: 26218750
[TBL] [Abstract][Full Text] [Related]
8. Antagonizing the Hedgehog Pathway with Vismodegib Impairs Malignant Pleural Mesothelioma Growth In Vivo by Affecting Stroma.
Meerang M; Bérard K; Felley-Bosco E; Lauk O; Vrugt B; Boss A; Kenkel D; Broggini-Tenzer A; Stahel RA; Arni S; Weder W; Opitz I
Mol Cancer Ther; 2016 May; 15(5):1095-105. PubMed ID: 26839306
[TBL] [Abstract][Full Text] [Related]
9. CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells.
Zhang S; Yang YL; Wang Y; You B; Dai Y; Chan G; Hsieh D; Kim IJ; Fang LT; Au A; Stoppler HJ; Xu Z; Jablons DM; You L
J Exp Clin Cancer Res; 2014 Nov; 33(1):93. PubMed ID: 25422081
[TBL] [Abstract][Full Text] [Related]
10. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors.
Arnhold V; Boos J; Lanvers-Kaminsky C
Cancer Chemother Pharmacol; 2016 Mar; 77(3):495-505. PubMed ID: 26781311
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic inhibition of Hedgehog-GLI signaling in cancer: epithelial, stromal, or stem cell targets?
Ruiz i Altaba A
Cancer Cell; 2008 Oct; 14(4):281-3. PubMed ID: 18835029
[TBL] [Abstract][Full Text] [Related]
12. Effective targeting of Hedgehog signaling in a medulloblastoma model with PF-5274857, a potent and selective Smoothened antagonist that penetrates the blood-brain barrier.
Rohner A; Spilker ME; Lam JL; Pascual B; Bartkowski D; Li QJ; Yang AH; Stevens G; Xu M; Wells PA; Planken S; Nair S; Sun S
Mol Cancer Ther; 2012 Jan; 11(1):57-65. PubMed ID: 22084163
[TBL] [Abstract][Full Text] [Related]
13. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.
Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI
Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014
[TBL] [Abstract][Full Text] [Related]
14. PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.
Kanteti R; Riehm JJ; Dhanasingh I; Lennon FE; Mirzapoiazova T; Mambetsariev B; Kindler HL; Salgia R
Sci Rep; 2016 Sep; 6():32992. PubMed ID: 27623107
[TBL] [Abstract][Full Text] [Related]
15. The hedgehog pathway and pancreatic cancer.
Hidalgo M; Maitra A
N Engl J Med; 2009 Nov; 361(21):2094-6. PubMed ID: 19923581
[No Abstract] [Full Text] [Related]
16. In vitro and in vivo characterization of a novel Hedgehog signaling antagonist in human glioblastoma cell lines.
Ferruzzi P; Mennillo F; De Rosa A; Giordano C; Rossi M; Benedetti G; Magrini R; Pericot Mohr Gl; Miragliotta V; Magnoni L; Mori E; Thomas R; Tunici P; Bakker A
Int J Cancer; 2012 Jul; 131(2):E33-44. PubMed ID: 22072503
[TBL] [Abstract][Full Text] [Related]
17. Tumor-stroma interaction in orthotopic primary pancreatic cancer xenografts during hedgehog pathway inhibition.
Chang Q; Foltz WD; Chaudary N; Hill RP; Hedley DW
Int J Cancer; 2013 Jul; 133(1):225-34. PubMed ID: 23280784
[TBL] [Abstract][Full Text] [Related]
18. Dipalmitoleoyl-phosphatidylethanolamine induces apoptosis of NCI-H28 malignant mesothelioma cells.
Kaku Y; Tsuchiya A; Kanno T; Nakano T; Nishizaki T
Anticancer Res; 2014 Apr; 34(4):1759-64. PubMed ID: 24692707
[TBL] [Abstract][Full Text] [Related]
19. SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma.
Zhang Y; He J; Zhang F; Li H; Yue D; Wang C; Jablons DM; He B; Lui N
J Exp Clin Cancer Res; 2013 Feb; 32(1):7. PubMed ID: 23379358
[TBL] [Abstract][Full Text] [Related]
20. Small molecule inhibitors of the hedgehog signaling pathway for the treatment of cancer.
Yun JI; Kim HR; Park H; Kim SK; Lee J
Arch Pharm Res; 2012 Aug; 35(8):1317-33. PubMed ID: 22941475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]